Antidepressant Market Will Remain Flat In Face Of Adult Suicidality Concerns, Forest Says

The impact of media attention on the adult suicide issue will be “hard to predict,” President & COO Goodman says. Forest expects FDA action on a Namenda supplemental NDA for mild-to-moderate Alzheimer’s in the next few weeks.